Walgreens appoints chief medical officer of Take Care Health Systems Consumer Solutions Group
DEERFIELD Ill. — Walgreens has announced the appointment of Alan London as chief medical officer of Take Care Health Systems Consumer Solutions Group.
In the newly created position, London will have leadership responsibility in building and maintaining external physician and health system relationships for Take Care Clinics while also providing strategic direction and leadership for the group’s service expansion, quality, clinical education and training, and collaborative practice agreement functions. London joined Walgreens on May 21.
“We are thrilled to appoint Dr. London as chief medical officer of the Consumer Solutions Group,” stated Jeffrey Kang, Walgreens SVP of pharmacy, health and wellness services and solutions. “We are confident his team-based, collaborative approach to health care and his diverse clinical and business background will prove him a valuable asset to Walgreens and Take Care Health. We look forward to his leadership as we diversify our service offerings, expand connections with managed care providers and continue to develop affordable and convenient ways of helping patients stay well.”
London is a family physician with more than three decades of experience in patient care delivery, healthcare strategy and business development. He has worked within the managed care contracting and risk management fields, while also spending extensive time in the hospital and healthcare system setting, serving at the Cleveland Clinic for 12 years.
Most recently, London was the president of the London Group International, a firm providing healthcare solutions for health systems, insurers, governments, physicians and the investment community. He is a co-founder of two healthcare companies, Clinically Home and MX.com.
No comments found
Net sales rise for Ahold USA in Q1
AMSTERDAM — Royal Ahold’s U.S. subsidiary saw net sales jump 2.8% to $7.8 billion during first quarter 2012, the company said Wednesday.
Ahold USA, which consists of such brands as Stop & Shop, Giant Carlisle, Giant Landover, Martin’s and Peapod, experienced a 1.4% increase in identical sales (0.1% excluding gasoline), as comparable-store sales were 1.8% for the quarter. Underlying operating margin dropped to 4.1% from 4.6% in the year-ago period. The company attributed last year’s solid sales growth to the "favorable timing of Easter (where the relatively low-sales post-Easter week shifted into the second quarter) and good operational execution during adverse weather events."
Commenting on the results, CEO Dick Boer said the company’s recent acquisition of 16 Genuardi’s stores in the Philadelphia market, as well as the U.S. online grocery shopping business, will help the U.S. subsidiary remain competitive in the market, but noted challenges that lie ahead.
"We continued to invest in competitiveness both in the United States and in Europe with higher levels of promotional activity, resulting in market share gains in the United States and maintaining our market share in the Netherlands," Boer said. "As we said before, we expect 2012 to be another challenging year for the food retail industry, with intense competitive activity and consumer spending under pressure due to economic uncertainty, particularly in Europe. We remain confident that our strong brands are well positioned and are well on track to deliver on our strategy."
Overall, Royal Ahold saw sales rise 9.7% to nearly $12.1 billion, while net profit slid from $363.4 million in first quarter 2011 to $352 million.
No comments found
RxAlly appoints former Medco executive to VP, chief privacy officer post
LEESBURG, Va. — A coalition of more than 22,000 pharmacies around the country has appointed a new VP and chief privacy officer.
RxAlly announced Tuesday the appointment of Peter Duran to the position, in which he’ll be responsible for the ensuring that the group’s privacy practices comply with laws and regulations.
Duran previously worked for pharmacy benefit manager Medco Health Solutions for 15 years, where he helped build the company’s privacy program.
"I share RxAlly’s passion for improving patient outcomes and lowering costs and am excited to work with the leadership team and network pharmacies to advance the role of pharmacists nationwide," Duran said.